TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING LAVAND OIL Russian patent published in 2019 - IPC A61K9/70 A61K36/53 A61F13/02 A61P25/20 

Abstract RU 2695785 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: group of inventions relates to the pharmaceutical industry. Disclosed is a transdermal therapeutic system (TTC) comprising: a) skin-back layer impermeable to the active substance; b) a depot layer of the active substance with content of 30–400 mg, which is selected from lavender oil, linalool or linalyl acetate; c) a matrix layer in contact with the active agent depot layer and regulating its release; d) a self-adhesive fixing layer on skin; e) a protective layer impermeable to the active substance, made with possibility of separation, wherein layers c) and d) can be identical or different, and depot-layer b) additionally comprises a support material comprising fibrous components. Invention also discloses a method of producing said TTC and use thereof for preventing and/or treating anxiety disorders, sleep disorders, phobias and nervousness.

EFFECT: group of inventions provides creating a therapeutic agent with controlled release of the active substance.

22 cl, 1 ex, 2 dwg

Similar patents RU2695785C2

Title Year Author Number
TOLTERODIN-CONTAINING TRANSDERMAL THERAPEUTIC SYSTEM (TTS) 2000
  • Art Kristof
  • Meeze Klaus
  • Shakht Ditrikh Vil'Khel'M
  • Vol'F Khans-Mikhaehl'
RU2251413C2
TRANSDERMAL THERAPEUTIC SYSTEM AND METHOD FOR PRODUCING THE SYSTEM 1993
  • Lotar Dojrer[De]
  • Tomas Khille[De]
  • Tomas Profitlikh[De]
  • Fritts Shtanislaus[De]
  • Kersten Val'Ter[De]
RU2108812C1
TRANSDERMAL THERAPEUTIC SYSTEM USING HEAT AVAILABLE TO ACCELERATE PENETRATION OF BIOLOGICALLY ACTIVE SUBSTANCES, AND APPLICATION THEREOF 2004
  • Mjuller Val'Ter
RU2348397C2
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE 2019
  • Mor, Patrik
  • Ritsher, Rene
  • Ejfler, Rene
  • Bourkuajn, Olga
RU2798017C2
TRANSDERMAL THERAPEUTIC SYSTEM (TTS) WITH FENTANYL AS ACTIVE SUBSTANCE 2002
  • Mjuller Val'Ter
RU2311908C2
COMPOSITION CONTAINING AT LEAST ONE ACTIVE SUBSTANCE INFLUENCING ON BLOOD LIPID LEVEL 1999
  • Bertol'D Akhim
RU2227023C2
TRANSDERMAL THERAPEUTIC SYSTEM FOR VOLATILE AND/OR THERMOLABILE SUBSTANCES 2006
  • Jung Tobias
  • Khorstmann Mikhaehl'
  • Dtsekan Khorst
RU2434631C2
HIGHLY PURE 3,3-DIPHENYLPROPYLAMINO MONOESTERS 2004
  • Brajtenbakh Armin
  • Meze Klaus
  • Vol'Ff Khans-Mikhaehl'
  • Drevs Roland
RU2394019C2
TRANSDERMAL ADMINISTRATION OF MEMANTINE 2011
  • Khorstmann Mikhael
  • Ajfler Rene
  • Kaufmann Regine
  • Mor Patrik
  • Galia Erik
  • Prange Volfgang
  • Buller Shtefan
  • Puzekker Klaus
  • Shtampfuss Jan
  • Shtelben Zjuzanne
RU2578971C2
DEVICE FOR TRANSDERMAL INTRODUCTION OF ROTIGOTINE IN ORGANISM IN FORM OF BASE 2003
  • Armin Brajtenbakh
RU2340339C2

RU 2 695 785 C2

Authors

Bottsem Petra

Khille Tomas

Dates

2019-07-26Published

2015-05-08Filed